Cargando…

The ovarian response prediction index (ORPI) as a clinical internal quality control to prevent ovarian hyperstimualtion syndrome

Detalles Bibliográficos
Autores principales:	Oliveira, Joao Batista A, Franco Jr, Jose G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brazilian Society of Assisted Reproduction 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264369/ https://www.ncbi.nlm.nih.gov/pubmed/27584597 http://dx.doi.org/10.5935/1518-0557.20160021

Ejemplares similares

A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation
por: Oliveira, Joao Batista A, et al.
Publicado: (2012)

MSOME/IMSI versus epigenetic marks: doubts in the past for hopes in the future
por: Franco Jr, Jose Gonçalves, et al.
Publicado: (2022)

Noninvasive preimplantation genetic testing for aneuploidies (niPGT-A) and the principle of primum non nocere
por: Franco Jr, Jose G., et al.
Publicado: (2020)

Initial ovarian sensitivity index predicts embryo quality and pregnancy potential in the first days of controlled ovarian stimulation
por: Camargo-Mattos, David, et al.
Publicado: (2020)

O-RADS: the evolution of the ovarian lesion classification system
por: Elias Jr., Jorge, et al.
Publicado: (2022)

Trends in endocrine onomastics: The case of polycystic ovarian syndrome
por: Kalra, Sanjay, et al.
Publicado: (2013)

Ovarian Cancer
por: Song, Yong Sang, et al.
Publicado: (2014)

Ovarian Tumors
Publicado: (1879)

New Hopes for the Treatment of Primary Ovarian Insufficiency/Premature Ovarian Failure
por: Sadeghi, Mohammad Reza
Publicado: (2013)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

On Tapping Ovarian Cysts
Publicado: (1900)

Heteroplastic Ovarian Grafting
Publicado: (1906)

Polycystic Ovarian Syndrome and Endometriosis as Two Evil Extremes of Health Continuum
por: Sadeghi, Mohammad Reza
Publicado: (2022)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Ovarian Tumor
Publicado: (1865)

Targeting Inflammation in Ovarian Cancer Through Natural Antioxidants, Potential Therapeutic and Preventive Implications
por: Singh, Mayank, et al.
Publicado: (2018)

Welcome to Journal of Ovarian Research
por: Palomba, Stefano, et al.
Publicado: (2008)

Linking omentum and ovarian cancer: NO
por: Rizi, Bahar Salimian, et al.
Publicado: (2015)

Screening for Ovarian Cancer: An Update
por: Patni, Ranu
Publicado: (2019)

Early detection of ovarian cancer
por: Forstner, Rosemarie
Publicado: (2020)

Translational Research in Ovarian Cancer
por: Di Renzo, Maria Flavia, et al.
Publicado: (2020)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

MR Imaging Findings of Ovarian Cystadenofibroma: Clues for Making the Differential Diagnosis from Ovarian Malignancy
por: Byun, Jae Young
Publicado: (2006)

A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index
por: Kawahara, Naoki, et al.
Publicado: (2021)

The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy
por: Yamanaka, Shoichiro, et al.
Publicado: (2022)

Ovarian Cancer: Latest Advances and Prospects
por: Dion, Ludivine, et al.
Publicado: (2021)

Mismatch repair deficiency in ovarian cancer
por: Fuh, Katherine
Publicado: (2022)

Treatment modalities for poor ovarian responders
por: Di Guardo, Federica, et al.
Publicado: (2023)

Ovarian Cancer: Advances in Pathophysiology and Therapies
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Comments on: Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
por: Kwon, Janice S.
Publicado: (2021)

Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF
por: Biasoni, Valentina, et al.
Publicado: (2011)

Peritoneal cancer index in ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

Does any serum marker predict the ovarian endometrioma accompanied with or without deep infiltrative endometriosis?
por: Horng, Huann-Cheng, et al.
Publicado: (2020)

Does the surgeon matter in the management of ovarian cancer?
por: Chan, K K
Publicado: (1999)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Chemotherapy for ovarian cancer: yesterday, today and tomorrow
por: Kaye, S B
Publicado: (2003)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jnjnn9apelhehbd2gmf41o4f5u